Sherry Layton

Company: Vetanco USA

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Achieving Harmonization Amongst all Stakeholders (Developers, Regulators, Manufacturers & End Users) to Expedite Approvals & Achieve Maximum Return of Investment for Effective Animal Vaccine Technologies 9:30 am

Where are the current gaps and misalignments amongst stakeholders to ensure success is achieved from submission through to approval of next generation animal health vaccines? How to balance the efficacy and safety concerns by regulatory agencies with consideration of the cost, practicality, and challenges faced in licensing the products?Read more

day: Conference Day Two

Inducing Mucosal Immunity Through the Use of Novel Platform Technologies 2:30 pm

How do mucosal vaccines differ from traditional injectable vaccines? How mucosal immunity is induced through novel technologies and the benefits of mucosal immunity in preventing diseases caused by bacterial, viral, and protozal pathogens How to understand which diseases can be more effectively controlled with mucosal vaccination over systemic vaccination to overcome low-efficacy systemic vaccines for…Read more

day: Conference Day Two